← Leaderboards
Robert A Schnoll
Fox Chase Cancer Center
$24,010,785
Attributed
$29,694,966
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,593,434 · 16
By mechanism
R01$26,610,535 · 9
P50$4,898,468 · 1
K24$1,524,200 · 1
R21$817,751 · 2
P30$571,617 · 2
R03$170,863 · 1
Top collaborators
- Robert Gross15 shared
- Rinad Sary Beidas7 shared
- Justin Bekelman7 shared
- Katherine L Nathanson4 shared
- Marylyn D Ritchie4 shared
Most similar at Fox Chase Cancer Center
Same institution · by research overlap
- Mary Beryl Daly$11,073,226
- Angela R. Bradbury$16,652,643
- Gregory P Adams$4,024,285
Others in their field
Top investigators on “Tobacco Use”
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Richard A Miech · Johns Hopkins University$52,176,244
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$51,945,159
- Stephen S Hecht · University Of Minnesota$36,298,608
- Stephen T Higgins · University Of Vermont &St Agric College$35,141,306
Research focus
Tobacco UseSmoking CessationSmokingProgramsSmokerTobaccoAreaDesignTobacco DependenceBaseNicotine DependenceSmoking Cessation InterventionPharmaceutical PreparationsResearch PersonnelAffectCounselingRandomizedLinkMediator Of Activation ProteinVareniclineGeneral PopulationClinical TrialsNicotine ReplacementMalignant Neoplasms
Grant awards (85)
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$812,074
R01 · FY2025 · HG
A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research$195,274
K24 · FY2025 · DA · contact PI
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$862,041
P50 · FY2024 · CA · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$790,117
R01 · FY2024 · HG
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$582,347
R01 · FY2024 · DA
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$215,558
R01 · FY2024 · CA · contact PI
A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research$196,426
K24 · FY2024 · DA · contact PI
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$144,477
R01 · FY2024 · CA · contact PI
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$143,970
R01 · FY2024 · DA
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$881,687
P50 · FY2023 · CA · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$877,709
R01 · FY2023 · HG
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$647,960
R01 · FY2023 · DA
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$606,133
R01 · FY2023 · CA · contact PI
A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research$197,545
K24 · FY2023 · DA · contact PI
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$146,491
R01 · FY2023 · DA
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$144,477
R01 · FY2023 · CA · contact PI
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$125,000
P50 · FY2023 · CA · contact PI
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$985,840
P50 · FY2022 · CA · contact PI
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure across a Diverse Health System$924,042
R01 · FY2022 · HG
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$616,693
R01 · FY2022 · CA · contact PI
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$607,604
R01 · FY2022 · DA
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research$186,991
K24 · FY2022 · DA · contact PI
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$985,840
P50 · FY2021 · CA
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$641,099
R01 · FY2021 · DA
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$620,489
R01 · FY2021 · CA · contact PI
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research$186,991
K24 · FY2021 · DA · contact PI
Tobacco and Environmental Carcinogenesis Program$83,107
P30 · FY2021 · CA · contact PI
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$75,000
P50 · FY2021 · CA
Advancing the Quality of Cancer Care through Behavioral Economics and Implementation Science$983,060
P50 · FY2020 · CA
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana$640,866
R01 · FY2020 · DA
Testing an Organizational Change Model to Address Smoking in Mental Healthcare$637,742
R01 · FY2020 · CA · contact PI
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$408,139
R01 · FY2020 · CA · contact PI
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research$186,991
K24 · FY2020 · DA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$77,524
P30 · FY2020 · CA · contact PI
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV$663,470
R01 · FY2019 · CA · contact PI
Testing an Organizational Change Model to Address Smoking in Mental Healthcare$629,507
R01 · FY2019 · CA · contact PI
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research$186,991
K24 · FY2019 · DA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$77,595
P30 · FY2019 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$7,213
P30 · FY2019 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$5,768
P30 · FY2019 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$3,627
P30 · FY2019 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$1,106
P30 · FY2019 · CA · contact PI
Testing an Organizational Change Model to Address Smoking in Mental Healthcare$653,852
R01 · FY2018 · CA · contact PI
A Patient-Oriented Research Mentoring Program in Tobacco Dependence Research$186,991
K24 · FY2018 · DA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$155,631
P30 · FY2018 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$9,404
P30 · FY2018 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$2,510
P30 · FY2018 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$2,142
P30 · FY2018 · CA · contact PI
Testing an Organizational Change Model to Address Smoking in Mental Healthcare$663,602
R01 · FY2017 · CA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$73,101
P30 · FY2017 · CA · contact PI
Testing an Organizational Change Model to Address Smoking in Mental Healthcare$690,705
R01 · FY2016 · CA · contact PI
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial$583,737
R01 · FY2016 · CA · contact PI
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS$499,927
R01 · FY2016 · DA · contact PI
Tobacco and Environmental Carcinogenesis Research Program$72,889
P30 · FY2016 · CA · contact PI
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial$599,076
R01 · FY2015 · CA · contact PI
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS$488,286
R01 · FY2015 · DA · contact PI
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial$594,156
R01 · FY2014 · CA · contact PI
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS$495,722
R01 · FY2014 · DA · contact PI
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial$587,033
R01 · FY2013 · CA · contact PI
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence$567,789
R01 · FY2013 · DA · contact PI
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS$475,893
R01 · FY2013 · DA · contact PI
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial$648,176
R01 · FY2012 · CA · contact PI
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence$601,611
R01 · FY2012 · DA · contact PI
A Placebo Controlled Trial of Varenicline for Smoking among those with HIV/AIDS$495,722
R01 · FY2012 · DA · contact PI
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence$625,923
R01 · FY2011 · DA · contact PI
Assessment of a Teachable Moment for Smoking Cessation$301,095
R01 · FY2011 · CA · contact PI
Efficacy of Varenicline for Smokless Tobacco Use in India$168,090
R21 · FY2011 · DA · contact PI
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence$638,503
R01 · FY2010 · DA · contact PI
Assessment of a Teachable Moment for Smoking Cessation$311,574
R01 · FY2010 · CA · contact PI
Efficacy of Varenicline for Smokless Tobacco Use in India$216,536
R21 · FY2010 · DA · contact PI
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine$196,875
R21 · FY2010 · DA · contact PI
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence$665,763
R01 · FY2009 · DA · contact PI
Assessment of a Teachable Moment for Smoking Cessation$306,648
R01 · FY2009 · CA · contact PI
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine$236,250
R21 · FY2009 · DA · contact PI
Assessment of a Teachable Moment for Smoking Cessation$468,487
R01 · FY2008 · CA · contact PI
Assessment of a Teachable Moment for Smoking Cessation$319,841
R01 · FY2007 · CA · contact PI
Smoking Cessation for Head and Neck Cancer Patients$543,137
R01 · FY2006 · CA · contact PI
Smoking Cessation for Head and Neck Cancer Patients$402,377
R01 · FY2005 · CA
Smoking Cessation for Head and Neck Cancer Patients$141,547
R01 · FY2005 · CA
Smoking Cessation for Head and Neck Cancer Patients$561,908
R01 · FY2004 · CA
Smoking Cessation for Head and Neck Cancer Patients$546,610
R01 · FY2003 · CA
Smoking Cessation for Head and Neck Cancer Patients$53,164
R01 · FY2003 · CA
Smoking Cessation for Head and Neck Cancer Patients$577,707
R01 · FY2002 · CA
SMOKING CESSATION FOR HEAD, NECK AND LUNG CANCER PATIENT$85,834
R03 · FY2001 · CA
SMOKING CESSATION FOR HEAD, NECK AND LUNG CANCER PATIENT$85,029
R03 · FY2000 · CA